IFOM Claudio Vernieri Lab

Claudio Vernieri Lab

Claudio Vernieri

Claudio Vernieri

Claudio Vernieri, M.D. Ph.D., specialized in Clinical Oncology and Cancer Metabolism. Since January 2020 he directs the Metabolic Reprogramming in Solid Tumors program at IFOM, and works as a medical oncologist in the Breast Unit of Fondazione IRCCS Istituto Nazionale dei Tumori. read more

Contact the researcher

Metabolic Reprogramming in Solid Tumors

When compared to normal cells, cancer cells are characterized by unrestrained growth and proliferation, which are sustained by an increased uptake, biosynthesis or catabolism of crucial metabolites, including glucose, amino acids, nucleotides and fatty acids.read more

Laboratory location: Milan, Italy

Recent publications

  1. Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, Michele Prisciandaro, Francesca Ligorio, Marta Brambilla, Pierangela Sepe, Francesca Corti, Giorgia Peverelli, Arianna Ottini, Teresa Beninato, Laura Mazzeo, Carmen G Rea, Gabriella Mariani, Filippo de Braud, Giulia V Bianch, Claudio Vernieri, Giuseppe Capri
    Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis
    Ther Adv Med Oncol. 2020 Dec 7;12:1758835920970081. doi: 10.1177/1758835920970081. eCollection 2020.

  2. Emma Zattarin, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, Claudio Vernieri
    Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
    Cells. 2020 Dec 9;9(12):2644. doi: 10.3390/cells9122644.

  3. Cristina Borzi, Giulia Galli, Monica Ganzinelli, Diego Signorelli, Claudio Vernieri, Marina Chiara Garassino, Gabriella Sozzi, Massimo Moro
    Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
    Pharmaceuticals (Basel). 2020 Nov 13;13(11):385. doi: 10.3390/ph13110385.

Group members

Temporary Fellow
Cantarelli Beatrice
Santamaria Marzia

(update: Mar 2021)

Collaborations

Prof. Giancarlo Pruneti: Fondazione IRCCS Istituto Nazionale dei Tumori
Dr. Serenella Pupa:Fondazione IRCCS Istituto Nazionale dei Tumori
Dr. Licia Rivoltini: Fondazione IRCCS Istituto Nazionale dei Tumori
Dr. Andrea Ciliberto: IFOM, the FIRC Institute of Molecular Oncology
Prof. Marco Foiani: IFOM, the FIRC Institute of Molecular Oncology
Prof. Valter Longo: IFOM, the FIRC Institute of Molecular Oncology
Prof. Saverio Minucci: IEO, European Institute of Oncology
Prof. Alessio Nencioni: Università degli Studi di Genova
Dr. Paola Corsetto: Università degli Studi di Milano